Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Human Cellular Medicine
Therapeutic Area : Technology
Study Phase : Undisclosed
Recipient : Kytopen
Deal Size : Undisclosed
Deal Type : Partnership
Details : Kytopen and Mirus Bio will collaborate to combine industry-leading technologies and tackle the non-viral delivery of highly complex genome engineering materials to help create human cellular medicines.
Brand Name : Undisclosed
Molecule Type : Cell and Gene therapy
Upfront Cash : Undisclosed
January 31, 2023
Lead Product(s) : Human Cellular Medicine
Therapeutic Area : Technology
Highest Development Status : Undisclosed
Recipient : Kytopen
Deal Size : Undisclosed
Deal Type : Partnership
LOOKING FOR A SUPPLIER?